Index of artpub/2022/pmc_9434412/

Borazanci, E
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors
2022
https://ddd.uab.cat/record/292133